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Since their inception, tetracycline (Tet)-inducible systems have
become the method of choice for transgenic research. The Tet-Off
systems have a number of advantages, including robust target
induction using a relatively benign effector molecule. However,
use of the Tet-On system has been fraught with difficulties,
including high background expression in the absence of effector
molecules and inconsistent gene induction. Recently, second-
generation Tet-On transactivators (TAs) have been described. In
HeLa cells, they are far more efficient than the original reverse TA
protein, and they exhibit lower background activity in the absence
of effectors. Here we examine the most promising TA in transgenic
Drosophila and characterize its in vivo properties. We report that
low levels of doxycycline, when added to normal fly food, effi-
ciently and rapidly induce target transgenes in adults, larvae, and
embryos. This TA is superior to all other Tet-On proteins, and its
performance is comparable to that of the widely used Tet-Off TA.
In addition, combining the improved Tet-On TA with the Gal4-UAS
(upstream-activating sequence) system produces robust, spatially
restricted, temporally controlled transgene induction. Because this
Tet-On TA is significantly more efficient than previous ones used in
Drosophila, it is also possible to modulate gene induction by
controlling the dosage of the antibiotic in the food.
Reverse genetic techniques are essential tools for researchersin the postgenome project era. The ability to express gene
products in a temporally restricted manner has been an essential
experimental strategy in determining gene function in tissue
culture and in vivo, where mutant or knockout studies are often
not practical. Currently, the best-characterized and most versa-
tile inducible approaches use the tetracycline (Tet)-mediated
expression systems (see ref. 1 for review). These rely on the
specific, high-affinity binding of the Escherichia coli Tet repres-
sor protein (TetR), or its derivatives, to the Tet operator (TetO)
sequences. When TetR is fused to the herpes simplex virus VP16
activation domain, the hybrid TetRyVP16 protein becomes a
powerful Tet-responsive transactivator (tTA). In the absence of
Tet or its analogs, the tTA protein binds TetO and initiates
transcription from artificial promoters containing these se-
quences. In the presence of the antibiotic, the TA binds the drug,
resulting in a conformational change that disrupts DNA binding
and inactivates transcription. The Tet-Off system has been
invaluable in addressing many biological problems where a
tightly regulated genetic switch is desirable.
A second Tet-regulated system was developed to address
biological problems where prolonged exposure to antibiotics is
undesirable (such as during development) or to express poten-
tially toxic target genes during very discrete periods of time. A
random mutagenesis of the TetR gene produced a protein that
bound to TetO sequences only in the presence of the Tet analog
doxycycline (dox) (2). Fusion of this mutant to VP16 produced
a reverse TA (rtTA), a protein that required drug interaction to
bind TetO sequences and activate transcription. This Tet-On TA
works well in most tissue culture applications, but is less effective
in transgenic animals, where there are only a handful of papers
reporting its use (3–6). Although the system works for certain
applications in mice, anecdotal reports indicate that it is uneven
in its performance. In many of these cases, induction kinetics is
slow and the fold induction is modest. It is likely that the reported
successes partially result from the determination of particular
combinations of transgenes that produce significant induction.
This empirical screening process, which is expensive and time
consuming, involves analyzing many TA and target transgenic
lines, and optimizing their combinatorial effectiveness (1). In
Drosophila, the production and analysis of transgenic flies is
routine and rapid, but combinatorial analysis is still difficult,
albeit not impossible. In mice, this type of analysis becomes
prohibitive.
Previously, the best performance of Tet-On in flies (a 10-fold
increase in b-galactosidase activity) required 2 days of dox
feeding (at 1 mgyml) and 3 additional days of accumulation (5).
This level of induction, although significant, was slow and
modest, despite the fact that the rtTA gene was expressed under
the control of the strong actin5C promoter. In this case, 13 TA
lines and six target lines had to be screened to find combinations
that produced this modest level of induction. In addition, many
of the combinations of transgenes exhibited high levels of leaky
expression (expression in the absence of the effector). Thus it is
not surprising that other Drosophila labs have reported that the
Tet-On system does not work in their experimental settings,
because a requisite number of combinations may not have been
screened (7).
Partially in response to the limitations of the first-generation
rtTA, a second screen for more effective Tet-On TAs was
undertaken. This screen produced a second-generation Tet-On
TA, rtTAs-M2, with increased induction capabilities and tighter
regulation (8). This TA consists of a second set of mutations that
reverse the binding properties of the protein. In addition, several
other changes were made to increase expression of the TA
protein. When assayed in HeLa cells, the combination of the M2
mutations and the changes to increase its expression result in
better induction at lower drug concentrations and less leakiness.
In parallel, we identified and removed a cryptic splicing site in
the TetR gene. When TetR is expressed in eukaryotic cells,
alternative splicing in the middle of the TetR coding region
results in nonproductive mRNA. Presumably, this usage of
cryptic splicing sites also occurs when TetR is fused in the tTA
and rtTA genes. We also adjusted the codon usage of the TetR
moiety to reflect mammalian frequencies, and the rtTA expres-
sion cassette was flanked with the Drosophila boundary elements
SCS and SCS9 (9, 10). These changes, referred to as altering the
rtTA gene, produced the rtTA-alt TA. In this study, the second-
generation mutations from the rtTAs-M2 allele are incorporated
into our altered rtTA gene, producing the rtTA-M2-alt TA. We
use the actin5C promoter to ubiquitously express the rtTA-M2-
alt TA in transgenic Drosophila and demonstrate its utility in
adult f lies, embryos, and larvae. This TA is compared directly to
all of the currently available Tet-inducible systems in Drosophila.
Finally, we have combined the Tet-On system with the Gal4-
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upstream-activating sequence (UAS) system to achieve both
spatial and temporal control of target transgene expression. This
study demonstrates that the rtTAs-M2 mutations, when com-
bined into the rtTA-M2-alt TA, function efficiently in transgenic
animals.
Methods
Construction of the rtTA-alt and rtTA-M2-alt Genes and Transgenic
Flies. The original bacterial Tn10 TetR coding sequence was
optimized for expression in mammalian cells. The signal se-
quences that defined a cryptic intron located between amino
acids 8 and 144 were altered to block splicing. The overall G 1
C content of the gene was increased from ’40% in the wild-type
TetR gene to ’50% in the optimized sequence. Although we
increased the overall G 1 C content, the occurrence of CpG
dinucleotides in the optimized sequence was maintained at a low
frequency consistent with mammalian coding sequences.
The codon usage of TetR was altered to improve expression
in mammalian cells by using the codon frequencies of porcine
albumin as a guide and through repeated codon bias analysis
with MACVECTOR software. The final gene was assembled in
pUC8 from four 100- to 160-bp double- stranded oligonucleo-
tides to produce the plasmid pSyntetR. This plasmid was then
used as the basis for producing the rtTA-alt genes. Site-directed
mutagenesis of pSyntetR was used to introduce the mutations
that change the binding properties of the TetR protein. This
mutated TetR gene was then fused to the VP16 activation
domain, producing a rtTA gene (rtTA-alt). This gene was placed
in an expression cassette, downstream of the actin5C promoter,
but upstream of a poly(A) addition site. A similar strategy was
used to assemble the rtTA-M2-alt gene, except that different
oligonucleotides were used for the site-directed mutagenesis and
introduction of the M2 mutations.
Expression cassettes consisting of either the rtTA-alt or
rtTA-M2-alt genes under the control of the actin5C promoter
were subcloned into a miniwhite P-element transformation
vector (pBlocker5). The plasmid pJY2005, which contains the
rtTA-alt gene, was assembled so that the boundary elements SCS
and SCS9 f lank the promoter, TA gene, and a poly(A) addition
sequence (Fig. 1). The plasmid pJY2006, which contains the
rtTA-M2-alt gene, was similarly constructed.
A target transgene, consisting of seven tandem TetO se-
quences, the cytomegalovirus minimal promoter, the luciferase
cDNA, a chicken b-globin intron, and a poly(A) signal was
subcloned into a standard miniwhite P-element transformation
vector (pJY2007). To facilitate usage of this system, we also
constructed universal acceptor vectors for insertion of desired
cDNAs. The uninsulated, universal vector (pJY2004) contains
seven tandem TetO sequences, the cytomegalovirus minimal
promoter, the unique restriction sites 59-XhoI and HpaI-39 for
cDNA insertion, the chicken b-globin intron, and a poly(A)
signal inside of a standard P-element transformation vector that
was derived from pCaSpeR4. These plasmids and detailed
information on the other ones used in this paper are available on
request. Transgenic flies were made and raised according to
standard procedures (11, 12). (For more information on TetO-
rpr f lies contact B.B.)
Dox Treatment. A 103 dox (Sigma) concentrate in PBS (pH ’7.2)
was added directly to our standard fly food. Fly food was
liquefied in a microwave and allowed to cool to 50°C. The 103
dox concentrate was added directly to the food and mixed, and
the food was allowed to resolidify. Because dox oxidizes rapidly
in the light, food is stored in the dark for a maximum of 24 h. Flies
treated with dox for longer than 24 h were transferred to fresh
dox-containing food daily. Larvae treated with dox-supple-
mented food were kept in the dark with periodic light flashes to
minimize oxidation of dox. Larvae were not transferred to fresh
dox-containing food. For experiments on embryos, mothers
were fed a yeast paste (containing dox, or not) spread on
standard agar egg-laying plates. The agar also contained dox,
or not.
For injection experiments, ’10 nl of dox was injected directly
into adult f lies by using a Tritech Research (Los Angeles)
injection setup with pulled glass needles. We adjusted the pH of
dox at 10 mgyml to ’7 by using 5 M NaOH. Needles were
inserted directly into the thorax (at the pterapleura) of anesthe-
tized flies, which were allowed to recover for at least 30 min
before time points were taken.
Western Blot Analysis. The Western blots shown in Fig. 2 were
performed with a mAb raised against firefly luciferase protein.
Purified luciferase protein was injected into mice, and mAbs
were raised by using standard techniques. Equal amounts of
protein were separated on standard protein gels, transferred to
nitrocellulose, blocked with 4% nonfat dry milk in TBST (Tris-
buffered saline with Tween 20), and probed with concentrated
luciferase antibody (diluted 1:750 in TBST). The blots were
washed and probed with a goat anti-mouse horseradish perox-
idase-conjugated secondary antibody before being visualized
with standard chemiluminescent techniques. The Western blot in
Fig. 3 was performed by using a rabbit polyclonal antibody
against the TetR protein (W.H., unpublished work). Twenty to
30 flies were flash-frozen and subsequently homogenized in 8 M
urea. Protein concentrations were determined by using the
Bio-Rad Protein Assay according to the manufacturer’s instruc-
tions. Twenty micrograms of protein from each sample was
separated by using SDSyPAGE and transferred, and Western
blots were performed as described (13). The Western blot in Fig.
3 was repeated and also probed with a polyclonal ADF-1
antibody (14) to confirm that all lanes were loaded and trans-
ferred equally (data not shown).
In Vitro Luciferase Assay. Twenty adult f lies were flash-frozen in
liquid nitrogen, ground into a powder, and refrozen in the
presence of buffer. The samples were thawed and homogenized,
and protein concentrations were determined by using the Bio-
Rad Dc protein assay. Luciferase assays were performed accord-
ing to the manufacturer’s instructions (Promega, Luciferase
Assay Kit). SEM was calculated by using standard equations.
Embryonic Immunocytochemistry. Embryonic immunocytochemis-
try was performed as described (14, 15). Concentrated luciferase
hybridoma supernatant was diluted 1:50 and preadsorbed
against 0- to 18-h wild-type embryos. Embryos were dechori-
nated, fixed, and incubated with preadsorbed antibody (diluted
Fig. 1. Our Drosophila Tet-On system. Two separate P-element constructs,
one using the actin5C promotor to ubiquitously express the rtTA-M2-alt
protein, the other carrying a target gene of interest under the control of the
Tet response elements (TetO), are combined in a single animal. In the presence
of the effector molecule, dox, transcription of the target transgene is acti-
vated. In the absence of dox, target transgene remains silent. The miniwhite
gene is used to select for transgenic lines. We use the boundary elements SCS
and SCS9 (labeled B) to insulate the rtTA-M2-alt expression cassette from
position effects.
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to a final concentration of 1:250) overnight at 4°C. The second-
ary antibody was an horseradish peroxidase-conjugated goat
anti-mouse diluted to a final concentration of 1:500 (Jackson
ImmunoResearch). Ni-diaminobenzidine-peroxidase was used
to visualize immune complexes as described (14).
5-Bromo-4-Chloro-3-Indolyl b-D-Galactoside (X-Gal) Staining of Lar-
vae. Wandering third-instar larvae were collected and washed in
PBS before being dissected in 4% paraformaldehyde (PBS).
Discs, brains, and various other larval parts were transferred to
X-gal staining solution for ’10 min. Larval parts were washed
repeatedly in PBS before being serially dehydrated in EtOH.
Larval brains and discs were cleared and mounted in Hemo-De
before being imaged.
Results
The Tet-On System in Adult Drosophila. Fig. 1 is a schematic cartoon
of the Tet-On system. The actin5C promoter is used to ubiqui-
tously express the rtTA-M2-alt protein. These transgenic flies
are crossed to flies carrying a target transgene whose expression
is controlled by seven tandem TetO sequences and a minimal
promoter. In this study, we use either the TetO-luciferase or
TetO-lacZ reporters as the target transgenes. Boundary (insu-
lator) elements are used to insulate the TA construct from the
effects of transcriptional elements flanking the site of transgene
insertion.
Dosage. Dox feeding induces reporter expression in adult f lies.
Transgenic flies homozygous for both the rtTA-M2-alt and
TetO-luciferase transgenes were placed on standard fly food
supplemented with varying amounts of dox. After 24 h, equal
amounts of total f ly protein were analyzed on Western blots by
using a luciferase-specific mAb. There was a direct relationship
between the dosage of dox fed to the flies and the level of
luciferase induction (Fig. 2 A). Target gene expression was barely
detectable in flies that did not have dox in their diet (Fig. 2 A,
lane 0). Significant induction was observed with antibiotic
concentrations as low as 1 mgyml, and there was a graded
response up to 1,000 mgyml, demonstrating the practicality of
Fig. 2. Analysis of the Tet-On TA (rtTA-M2-alt) in adult flies. (A) Dose curve for
targetgene induction.Double transgenicfliesweremaintainedondox-free food
(0) or food supplemented with 1, 10, 100, or 1,000 mgyml of dox for 24 h. Whole
fly extracts were analyzed on Western blots using a luciferase mAb. Extracts also
were made from control flies carrying two copies of the luciferase target trans-
gene (2), without a TA transgene, and not fed antibiotic. (B) Induction kinetics of
flies fed dox at 10 mgyml. Double transgenic flies were frozen immediately (0), 6,
12, 24, 36, or 48 h after being placed on dox-containing food (10 mgyml), extracts
were prepared, and Western blot analysis was done with the luciferase antibody.
Extracts also were made from control flies carrying two copies of the target
transgene without a TA (2), and not fed antibiotic. (C) Induction kinetics of flies
fed dox at 1 mgyml. Double transgenic flies were frozen immediately (0), 1, 3, 6,
12,24,or48hafterbeingplacedondox-containingfood,extractswereprepared,
and Western blot analysis was done with the luciferase antibody. Extracts also
weremadefromcontrolflies carryingtwocopiesof thetarget transgenewithout
a TA (2), and not fed antibiotic. (D) Induction kinetics of flies injected with dox.
Double transgenic flies were injected with ’1 nl of a 10 mgyml dox solution, and
extracts were prepared 30 min, 1, 3, 6, or 12 h after injection. Extracts also were
made from flies injected with PBS (Mock), or single transgenic flies missing the TA
(2) and uninjected. Levels of induction: (E) Effect of TA gene dosage on target
gene expression levels. Flies carrying one or two copies of the rtTA-M2-alt and
two copies of a luciferase target transgene were frozen at 0, 12, or 24 h after
being placed on dox-containing food (1 mgyml). Extracts also were made from
control flies containing two copies of the luciferase target transgene without a
TA source (2) and not fed antibiotic. Western blot analysis was done with the
luciferase antibody. (G) Quantitative analysis using in vitro luciferase assays.
Twelve hours after the start of drug feeding, extracts from flies containing one
(rtTA-M2-altyCyO)ortwo(rtTA-M-altyrtTA-M2-alt) copiesoftheTAwereassayed
for luciferase activity. (F) Estimate of the absolute amount of luciferase protein
that is induced. Western blot analysis of extracts using a luciferase-specific mAb.
Twenty micrograms of total protein from double transgenic flies fed antibiotic
(1Dox), or not (2Dox), was compared with extracts from wild-type flies supple-
mented with known quantities (1, 2.5, or 5 ng) of purified luciferase protein.
Fig. 3. Comparison of the various TAs. (A) Western blot analysis of TA levels.
Equivalent amounts of total extract protein from flies carrying one copy of the
various TAs were probed with a TetR-specific antibody. All TAs were expressed
from the actin5C promoter. Wild-type flies (2) without any TA and flies
containing an unaltered Tet-Off (tTA), unaltered Tet-On (rtTA), altered
Tet-On (rtTA-alt), and altered M2 (rtTA-M2-alt) TAs were compared. (B)
Comparison of TA activity using in vitro luciferase assays. Double transgenic
Tet-On flies were fed dox-containing food (1 mgyml) for 24 h, then assayed for
luciferase activity. Double transgenic Tet-Off flies were maintained on regular
food before luciferase measurements. Flies containing the unaltered, original
Tet-On TA (rtTA) produced no detectable luciferase induction, and this value
was set to one. All other values are relative to this amount of luciferase.
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modulating levels of induction by varying the drug concentration
in the food. Luciferase expression was undetectable in flies that
carried two copies of the target transgene without a TA source
(Fig. 2 A, lane designated 2).
Kinetics of Induction. The kinetics of target gene induction
depends on the concentration of dox in the food. Flies were
maintained on dox-containing food (10 mgyml, Fig. 2B, or 1
mgyml, Fig. 2C) for varying amounts of time, and equal amounts
of total f ly protein were analyzed for luciferase expression by
using Western blots. When flies were fed dox at 10 mgyml,
luciferase induction was detected within 12 h. The amount of
luciferase protein continued to increase until some time point
between 36 and 48 h, when expression reached a plateau (data
not shown). When flies were fed dox at 1 mgyml, significant
luciferase induction was detectable in 3 h, and this induction
peaked sometime between 24 and 48 h. There was no further
increase beyond the levels achieved at 48 h (data not shown).
Flies maintained on food supplemented with dox at concentra-
tions higher than 1 mgyml for 48 h appeared slightly sluggish
(data not shown) and were not analyzed further.
If the kinetics depends on the concentration of dox in the food,
direct injection of the antibiotic into adult f lies should greatly
accelerate the process, because it bypasses the slow and uncon-
trolled steps of feeding and metabolism. To test this, we injected
dox (10 mgyml) into the thoracic cavity of flies. Groups of flies
were frozen at various times after injection, and equal amounts
of protein were analyzed with Western blots (Fig. 2D). Robust
luciferase induction occured within 30 min, and there was no
further increase at later time points. These data indicate that the
kinetics of drug delivery to the fly limits the kinetics of target
gene induction and can be optimized by directly injecting the
antibiotic into the animal. There was no detectable increase in
luciferase expression in flies mock-injected with PBS.
Leakiness. There was detectable, but low-level, leakiness in the
absence of drug. Flies that contained only the target transgene
(Fig. 2 A–C, lanes marked 2) had undetectable levels of
luciferase expression. When the TA transgene was crossed into
these flies, but the flies were not fed any antibiotic, a low level
of luciferase expression could be detected (Fig. 2 A–C, lanes
designated 0). The difference in expression between these flies
(Fig. 2 A–C, 2 versus 0) was defined as the amount of leakiness.
The background activity detected was likely to be caused by the
low affinity of rtTA-M2 protein for TetO sequences in the
absence of effector, but was significantly lower than levels
observed with the original rtTA protein. However, when com-
pared with the maximal induced levels, the amount of leaky
expression in the rtTA-M2 system was insignificant.
Amount of Induction. What limits the level of induction? It is likely
that the concentration of the TAydrug complex limits the
amount of target gene induction. We compared the effect of TA
gene dosage on luciferase induction. Flies heterozygous or
homozygous for the TA gene were fed antibiotic (1 mgyml), and
equal amounts of protein were analyzed with Western blots.
After both 12 and 24 h of feeding, homozygous flies produced
more luciferase than flies with a single copy (Fig. 2E). Quan-
titative analysis confirmed the Western blot analysis (Fig. 2G).
Homozygous flies fed dox for 12 h produced roughly twice as
much luciferase activity as heterozygous flies. Together, the
Western blots and luciferase assays show that increasing the copy
number, and presumably the amount of the TA protein, in-
creases target gene induction.
Absolute level of target protein that is induced. We estimate that
the dox-induced luciferase protein represents about 1 in 20,000
total protein molecules. Flies homozygous for both TA and
target transgenes were fed dox (1 mgyml) for 48 h (Fig. 2F,
1Dox). Twenty micrograms of total f ly protein was compared
with protein from untreated flies (Fig. 2F, 2Dox) and protein
from wild-type flies that were supplemented with defined
amounts (1–5 ng) of purified luciferase protein. Western blot
analysis showed that about 1–2 ng of luciferase protein was
induced per 20 mg of total protein. When simplifying assump-
tions are made, this amount of induced protein corresponds to
’1 in 20,000 total molecules.
Comparison of Various TAs. TA expression levels. Altering the codon
usage, removing a cryptic splicing site, and insulating from
position effects increases TA expression. We refer to these three
modifications collectively as altering the TA. Three versions of
the rtTA and the tTA were expressed under the control of the
actin5C promoter and compared for protein expression. Equal
amounts of whole fly protein from the different transgenic flies
were analyzed by using Western blots and a polyclonal antibody
raised against the TetR protein (Fig. 3A). When either the
original Tet-On (Fig. 3A, rtTA-alt 5 lane 2) or the new M2 (Fig.
3A, rtTA-M2-alt 5 lane 1) genes were altered, TA protein could
be detected. TA protein was undetectable in wild-type flies (Fig.
3A, lane 5), or flies with either the unaltered Tet-Off (Fig. 3A,
tTA 5 lane 4) or the original, unaltered Tet-On (Fig. 3A, rtTA 5
lane 3) TA (5). Thus, the net effect of altering the TA was to
increase expression.
Induction capabilities. rtTA-M2-alt lines function comparably
to the Tet-Off TA lines. Double transgenic flies carrying the
various Tet-On TAs and target were fed dox (1 mgyml) for 24 h.
Transgenic Tet-Off f lies (with targets) were maintained on
regular food. Whole fly extracts were prepared, and equal
amounts of protein were assayed for luciferase activity (Fig. 3B).
Consistent with a previous report, the rtTA failed to induce
significant amounts of luciferase when flies were fed for only 24 h
at 1 mgyml dox (5). This value was arbitrarily set to a value of
one, and all other levels were normalized to this number.
Altering the TA resulted in an increase in TA expression and an
approximate 8-fold induction of luciferase activity (rtTA versus
rtTA-alt). This result demonstrates that increasing the expres-
sion levels of the TA leads to greater luciferase induction. The
new M2 allele, when altered, results in a 68-fold induction of
luciferase activity. When compared with the rtTA-alt, which is
expressed at comparable levels, it results in 8.5-fold greater
induction. This improvement results from the set of mutations
that make the M2 protein a better TA. The Tet-Off TA produces
a 119-fold induction, or about twice that of rtTA-M2-alt. How-
ever, the tTA is expressed at significantly lower levels, indicating
that the tTA protein is far more active than the rtTA-M2-alt
protein.
The rtTA-M2-alt Functions in Both Embryos and Larvae. Embryos.
Significant induction of luciferase was detected in embryos from
mothers that were fed dox-containing food. Embryos (6–18 h)
were collected from mothers homozygous for both the rtTA-
M2-alt and TetO-luciferase transgenes. Robust, ubiquitous lu-
ciferase staining was detected in embryos from mothers main-
tained on food supplemented with dox (100 mgyml) for 48 h
before embryo collection (Fig. 4A Upper). Luciferase was un-
detectable in embryos from mothers who were maintained on
dox-free food (Fig. 4A Lower). Early embryos (0–2 h) from
double transgenic animals, wild-type embryos, or embryos lack-
ing the TA transgene did not produce any detectable staining
(data not shown). The lack of detectable staining in early
embryos indicates that the staining in older embryos is likely to
be a result of zygotic target transgene expression.
Larvae. Strong induction of a TetO-LacZ transgene (5) was
detected in larvae raised on food supplemented with dox. Larvae
heterozygous for both the rtTA-M2-alt and TetO-LacZ trans-
genes were raised on food supplemented with dox (10 mgyml) or
on regular food. Wandering third-instar larvae were dissected,
fixed, and stained for b-galactosidase activity. Strong, dox-
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dependent X-gal staining was detected in dissected larval brains,
wing discs, and leg discs (Fig. 4 B–D, 1). Discs from mothers that
were fed drug-free food (Fig. 4 B–D, 2) showed no staining.
Single transgenic larvae, carrying either the TA or target trans-
genes only, or wild-type larvae, did not produce any detectable
X-gal staining in their discs (data not shown). Previous studies
using an actin5C-driven rtTA transgene required high dox
concentrations (up to 250 mgyml) to produce target gene induc-
tion (5). In our hands, larvae fed dox at these high concentrations
suffered clear effects on developmental morphology and behav-
ior consistent with previous findings (5). We saw no adverse
effects on larvae when they were fed dox at 10 mgyml.
Discussion
We describe the application of a second-generation Tet-On TA
(rtTA-M2-alt) to transgenic animals and compare its perfor-
mance to previously available Tet-regulated systems in vivo.
Rapid and strong induction of target transgenes occurs through-
out the animal. This expression is dox-dependent, sensitive to the
dosage of drug in the food, and requires the presence of both TA
and target transgenes. These properties, in adult f lies, embryos,
and larvae, validate the use of the system for transgenic appli-
cations. The TA protein produced from our rtTA-M2-alt gene is
slightly different from the one previously reported (8). Our
protein has a cryptic splicing site removed in the TetR moiety,
and the VP16 activation domain is larger. It is unclear which
version of the M2 TA is more efficient. However, it is very clear
that the M2 mutations result in a better TA, with faster induction
kinetics, lower drug requirements, and greater induction.
In adult f lies, induction of a luciferase target can be achieved
when standard Drosophila food is supplemented with dox at
concentrations as low as 1 mgyml, although maximum induction
requires concentrations of 100–1,000 mgyml. The kinetics of
induction is concentration-dependent, and significant induction
can occur within 3 h. Induction continues to increase until a
plateau is reached sometime between 24 and 48 h. When the
drug is directly injected into adult f lies, maximal induction is
detected within 30 min, and these flies are healthy and viable
(data not shown). These results represent a significant improve-
ment over the performance of the original Tet-On system in flies
(5), where significant accumulation of b-galactosidase required
at least 48 h of feeding followed by 3 days of ‘‘recovery.’’ Also,
in the previous study, dox was administered in a Tris-sucrose
solution. Altering feeding conditions can have a dramatic effect
on many adult behaviors. By placing dox in standard fly food,
researchers will be able to avoid the complications of changing
feeding conditions.
The amount of induction depends on the dosage of antibiotic
and the duration of feeding. Maximal induction is easily achieved
with dox concentrations as low as 10 mgyml when flies are fed for
48 h. At 1 mgyml, which is the highest concentration that we
recommend feeding adult f lies, the maximum amount of induc-
tion (’68-fold) is still sensitive to the gene dosage of the TA.
Therefore, transgenic lines that have higher basal level expres-
sion of the TA should result in greater induction of the target
gene. The amount of induction we measure by using our Tet-On
TA results from a combination of two factors. Altering the TA
leads to better expression, which contributes about an 8-fold
improvement in induction. The M2 mutations result in a better
reverse TA protein, which contributes approximately another
8-fold. Together, our Tet-On TA performed 68-fold better than
the rtTA protein, and this amount of induction was within 2-fold
of what is achievable with the Tet-Off TA. Therefore, in
transgenic animals, greater induction and faster kinetics can be
achieved by finding transgenic lines with more TA expression or
delivering the antibiotic to the tissue of choice in as direct a
manner as possible.
We also have demonstrated that the Tet-On system can be
used to induce target transgenes throughout embryos and larvae.
If mothers are fed dox (100 mgyml), their embryos show strong
induction. Massive induction of a LacZ transgene is detected in
larvae reared on food supplemented with dox at 10 mgyml in all
tissues tested. The previously published rtTA-based system had
marginal utility in larvae. Larvae had to be fed dox at 250 mgyml
to induce expression from the same LacZ transgene that we are
inducing effectively at 10 mgyml (5). There are clear morpho-
logical and behavioral effects on larvae when they are fed dox at
the higher concentration. Larval studies using the rtTA-M2-alt
system will now be able to proceed without fear of toxicity.
The combination of the Tet-On and Gal4-UAS systems pro-
vides a powerful reverse genetic tool (see Results in the sup-
porting information and Figs. 5 and 6, which are published on the
PNAS web site, www.pnas.org). We demonstrate that a seven-
less-Gal4 driver is able to bring expression of rtTA-M2-alt to
high enough levels to achieve a 40-fold induction of a luciferase
target transgene upon dox feeding. Several other eye- and
brain-specific drivers showed similar results (not shown). How-
ever, it should be noted that the fold induction will vary greatly
depending on the Gal4 driver and target transgenes used. In
adults there is only a 1.3-fold difference in expression levels
between flies with and without a Gal4 driver. These results
suggest that almost all of the TA protein is inactive in the absence
of drug. Despite the low leakiness the system exhibits high
induction ratios. Because of the instability of a luciferin-
luciferase complex, luciferase accumulation is unlikely to con-
tribute to an overestimation of the amount of induction. It is
likely that the spatially restricted system will have similar kinetics
to the actin-based system because the amount of induction at
24 h is similar in both systems. However, the detailed pharma-
cokinetics of drug delivery may vary in different tissues and
needs to be empirically determined.
Tissue-specific, concentration-dependent expression is further
demonstrated when the system is used to cause defects in wing
structures upon expression of rpr. The improved Tet-On system
Fig. 4. Analysis of our Tet-On TA in embryos and larvae. (A) Mothers carrying
two copies of both the actin5C-rtTA-M2-alt transgene and the TetO-luciferase
transgene were fed yeast paste supplemented with dox (100 mgyml) for 48 h
(1), or dox-free yeast paste (2). Embryos of 6–18 h were dechorinated, fixed,
and incubated with an antiluciferase mAb overnight at 4°C. Antibody com-
plexes were detected with an horseradish peroxidase-conjugated secondary
antibody and Ni- diaminobenzidine staining. (B–D) Wandering third-instar
larvae carrying one copy of both the actin5C-rtTA-M2-alt and the TetO-LacZ
transgenes were dissected, fixed, and stained with X-gal. Brains (B), wing discs
(C), and leg discs (D) from larvae fed dox-containing (1) food (10 mgyml) or
regular food (2) were compared. No staining was detected in wild-type larvae
or larvae carrying only the TetO-LacZ transgene (data not shown).
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allows temporal control of gene induction and concentration-
dependent modulation of the amount of induction. These prop-
erties should facilitate analyses of late phenotypes, because many
enhancers express in earlier patterns, and these may interfere
with analyses of later phenotypes. This principle is illustrated
with the Salm enhancer, because traditional Salm-Gal4yUAS
expression of rpr is lethal, but control of drug dosage and rpr
expression allows development to proceed normally, revealing
late wing and eye phenotypes. Spatially restricted induction also
should complement currently available induction systems to
define tissue and temporal requirements for gene activity in any
biological process.
It is our sense that part of the reason for our success is the use
of boundary elements to minimize position effects of random
insertions (9, 10, 16–19). In this report, we insulate only the TA
expression cassette and do not insulate the target. When target
transgenes are insulated and compared with uninsulated ones,
we find that insulators generally increase expression levels, but
do not change the fold induction (M.J.S., unpublished data).
Most insulated target transgenes had the same baseline and
induced expression levels. Similarly, four combinations of insu-
lated TA lines performed equally when combined with the same
target line. This equivalence decreased the number of trans-
genes, and combinations of transgenes, that we examined, be-
cause most were nearly identical (M.J.S., unpublished data).
We and others have shown that the second-generation Tet-On
TA works well in transfected HeLa cells (8), primary neurons (Z.
Lin, personal communication), mice (19), and transgenic flies.
These experimental systems differ in many details that affect
transcription. However, all of the important measures of the
performance of an inducible system (induction ratio, kinetics of
induction, leakiness, and possible toxic or pleiotropic effects of
dox) are similar in the various cells, regardless of species,
developmental stage, or tissue type. This type of uniformity of
performance bodes well for future applications in other trans-
genic and cellular contexts. The improvements in the Tet-On
system have allowed us to successfully combine the Gal4-UAS
and Tet-On systems, resulting in spatially restricted, temporally
regulated gene induction upon drug feeding. The combined Gal4
Tet-On system represents a major improvement to inducible
technology in Drosophila with implications for other transgenic
model systems. Finally, this study provides a benchmark to which
future improvements to the Tet-On system can be compared.
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